FlareHawk Logo
Accelus Announces New Milestone with Its FlareHawk® Interbody Fusion System Surpassing 15,000 Devices Implanted
October 11, 2022 08:45 ET | Accelus
PALM BEACH GARDENS, Fla., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...
EB Headshot VSON Logo
Accelus Announces Vail-Summit Orthopaedics and Neurosurgery as First Ambulatory Surgery Center to Adopt Remi™ Robotic Navigation System
July 14, 2022 12:37 ET | Accelus
PALM BEACH GARDENS, Fla., July 14, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...
accelus-logo_4c.png
Accelus Announces Series D Equity Financing Led by Concord Health Partners (CHP
July 12, 2022 08:15 ET | Accelus
• CHP Co-Founder and Partner Joseph Swedish Named to Accelus Board of Directors PALM BEACH GARDENS, Fla., July 12, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology...
Lisa Jacobs, Accelus VP of Sales
Accelus Announces Sales Leadership Appointments, Establishes U.S. East and West Sales Leaders
June 13, 2022 08:45 ET | Accelus
Lisa Jacobs promoted to serve as Vice President of SalesJim Fox promoted to East U.S. Vice President of SalesJay Shellhammer promoted to West U.S. Vice President of Sales PALM BEACH GARDENS, Fla.,...
Toro-L Interbody Fusion System
Accelus Receives U.S. FDA 510(k) Clearance for its Toro-L Interbody Fusion System
May 19, 2022 08:35 ET | Accelus
PALM BEACH GARDENS, Fla., May 19, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...
th11_web
Accelus Receives U.S. FDA 510(k) Clearance for its FlareHawk TiHawk11 Interbody Fusion System
May 12, 2022 08:25 ET | Accelus
PALM BEACH GARDENS, Fla., May 12, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...
Accelus launches the TiHawk7 Titanium-Bonded Multidirectionally Expanding Interbody Case to Support Endoscopic and MIS Lumbar Fusion Procedures
Accelus Launches TiHawk7™ Titanium-Bonded Multidirectionally Expanding Interbody Cage to Support Endoscopic and MIS Lumbar Fusion Procedures
May 05, 2022 08:20 ET | Accelus
PALM BEACH GARDENS, Fla., May 05, 2022 (GLOBE NEWSWIRE) -- Accelus, a medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in...
accelus-logo_4c.png
Sun Sentinel Names Accelus a Winner of the South Florida Top Workplaces 2022 Award
May 02, 2022 08:45 ET | Accelus
PALM BEACH GARDENS, Fla., May 02, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...
FlareHawk7 headon
Accelus Launches Ultra-Low-Profile FlareHawk7™ Expandable Cage Implant and Innovative Instruments to Support Endoscopic, MIS Lumbar Fusion Procedures
August 17, 2021 10:42 ET | Accelus
PALM BEACH GARDENS, Fla., Aug. 17, 2021 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...